Publication | Open Access

Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial

VaccinationVaccine SafetyVaccine DevelopmentVaccine TargetImmunologyVaccine TestingVirologyDose-escalation TrialMedicineVaccine ResearchPhase 1Healthy Adults